PRESS RELEASE published on 06/19/2023 at 12:30, 1 year 4 months ago Anniversary of BRAIN Biotech AG: 30 years for a bio-based future
PRESS RELEASE published on 05/25/2023 at 07:30, 1 year 5 months ago BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy
PRESS RELEASE published on 05/24/2023 at 09:30, 1 year 5 months ago BRAIN Biotech AG gains full ownership of Biocatalysts Ltd and accelerates execution of its One-BioProducts Strategy
PRESS RELEASE published on 03/08/2023 at 17:20, 1 year 7 months ago Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
PRESS RELEASE published on 02/27/2023 at 16:00, 1 year 8 months ago Capital Markets Day 2023: BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
PRESS RELEASE published on 02/27/2023 at 07:30, 1 year 8 months ago BRAIN Biotech AG with Strong Start into Fiscal Year 2022/23, 3M Reporting
PRESS RELEASE published on 02/22/2023 at 14:00, 1 year 8 months ago BRAIN Biotech and TransCode Therapeutics join forces to develop a CRISPR-derived technology platform for cancer treatment
PRESS RELEASE published on 02/10/2023 at 11:04, 1 year 8 months ago EQS-Adhoc: BRAIN Biotech AG terminates contract for natural sweetener solution with Roquette Frères
PRESS RELEASE published on 01/16/2023 at 07:30, 1 year 9 months ago BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment
PRESS RELEASE published on 01/10/2023 at 12:15, 1 year 9 months ago BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
Published on 11/08/2024 at 14:00, 31 minutes ago NOA Lithium Closes $912,596 1st Tranche of the $2.7 Million Non-Brokered Private Placement
Published on 11/08/2024 at 14:00, 31 minutes ago Ballpoint Marketing - Leader in Handwritten Mail - Acquires a Friendly Competitor: Robot Ink Marketing
Published on 11/08/2024 at 13:30, 1 hour 1 minute ago Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Published on 11/08/2024 at 13:05, 1 hour 26 minutes ago Aton Announces Corporate and Operations Update
Published on 11/08/2024 at 13:00, 1 hour 31 minutes ago Honey Badger Announces Change of Transfer Agent
Published on 11/08/2024 at 12:31, 2 hours ago Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:25, 2 hours 6 minutes ago freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 2 hours 20 minutes ago PNE AG selected by the European Commission for funding a project to produce hydrogen
Published on 11/08/2024 at 12:32, 1 hour 59 minutes ago Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 1 hour 59 minutes ago Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 16 minutes ago Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 16 minutes ago Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 6 hours 31 minutes ago DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
